Navigation Links
Proscar Won't Boost Prostate Cancer Survival, Study Finds
Date:2/17/2013

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 15 (HealthDay News) -- Men with prostate cancer taking the drug finasteride (Proscar) don't survive longer than similar men not taking the drug, a new study finds.

Although Proscar is touted to reduce the odds of being diagnosed with prostate cancer, once diagnosed, men do not appear to gain a benefit from the drug, researchers say.

However, they don't face lowered survival from the drug, a researcher added.

"There is no evidence that finasteride is worse than placebo, in terms of overall survival," said lead author Phyllis Goodman, a biostatistician at the Fred Hutchinson Cancer Research Center, in Seattle.

"If you are inclined to give finasteride to prevent cancer, survival shouldn't be a reason not to do it," she said. "You may not be improving survival in the long run, but you are avoiding having to deal with a diagnosis of prostate cancer."

Based on the new finding, one expert doesn't recommend men take Proscar.

"This lessens the importance of finasteride, because if you wanted to use it as a preventive measure you hope the death rate would go down," said Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital, in Boston.

One problem with the study is that it deals with overall deaths -- not deaths specifically caused by prostate cancer. So it's hard to tell how effective Proscar really is, D'Amico said.

"Without a survival improvement it's hard to justify using the drug," he said. "Let me see what the cancer-specific survival looks like and then we can decide if it's appropriate at all."

The results of the study were presented Thursday at the annual Genitourinary Cancers Symposium in Orlando, Fla. The data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

For the U.S. National Cancer Institute-funded study, researchers collected data on deaths of men taking Proscar or an inactive placebo who were located in a Social Security database of deaths.

The investigators found that among 18,000 men who had been taking Proscar for seven years, there were more than 5,000 deaths. Of these, 2,584 deaths were among men taking Proscar and 2,544 deaths were among men taking placebo.

Over 15 years of follow-up, the survival rate was 78 percent for men in both groups, the study found.

Although men suffering from the most aggressive prostate cancers saw no benefit from Proscar, men with less aggressive cancer taking the drug did have a significant survival advantage, compared to men receiving placebo, the researchers found.

In 2011, the U.S. Food and Drug Administration placed a black-box warning on Proscar for a slight but statistically significant risk that its use could cause aggressive prostate cancer. The drug has several side effects including impotence and loss of interest in sex.

In the new study, the bottom line for the researchers is that "finasteride administration for seven years does not appear to affect mortality but significantly reduces the risk of a prostate cancer diagnosis."

Another expert gave his perspective on the drug.

"At this point, I think that the data is showing that the drug may not be of any significance to patients," said Dr. Louis Kavoussi, chairman of urology at North Shore-LIJ Arthur Smith Institute for Urology in New Hyde Park, N.Y.

However, Proscar may slow the progression of prostate cancer, he said.

"There are individuals who may benefit from being put on this drug and may rest a little bit easier at night knowing that it may not have a negative outcome on their long-term survival," Kavoussi said.

More information

To learn more about prostate cancer, visit the American Cancer Society.

SOURCES: Phyllis Goodman, Fred Hutchinson Cancer Research Center, Seattle; Anthony D'Amico, M.D., Ph.D., chief, genitourinary radiation oncology, Brigham and Women's Hospital, Boston; Louis Kavoussi, M.D., chairman of urology, North Shore-LIJ Arthur Smith Institute for Urology, New Hyde Park, N.Y.; Feb. 14, 2013, presentation, 2013 Genitourinary Cancers Symposium, Orlando, Fla.


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Avastin May Help Boost Survival With Aggressive Cervical Cancer: Study
2. A Good Mood May Boost Seniors Brain Power
3. Living Near Equator May Boost Your Risk for Allergy, Asthma
4. Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy
5. Fried Foods May Boost Prostate Cancer Risk, Study Says
6. Plastic Surgery Practice Gets Boost from Lower Eyelid Surgery Webinar
7. Get Bigger Buttocks
8. How “Bigger Butt Secrets” Helps Women Boost Their Butt Naturally – Tony Nguyen
9. Diet, parental behavior, and preschool can boost childrens IQ
10. Oxygen chamber can boost brain repair
11. Cognitive Decline May Be Reversible with Brain-Boosting Vitamins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Proscar Won't Boost Prostate Cancer Survival, Study Finds
(Date:5/3/2016)... ... May 03, 2016 , ... AvePoint, ... release of DocAve 6 Service Pack (SP) 7, the enterprise-class infrastructure ... 2016 and take advantage of the platform’s latest features – whether in an ...
(Date:5/3/2016)... ... May 03, 2016 , ... LunchSkins is changing the future of ... of single-use, throw away plastic baggies. The mission-driven bags give back to global leaders ... “The LunchSkins mission is all about reducing global plastic waste and we’ve ...
(Date:5/2/2016)... ... May 03, 2016 , ... ... FDA approved sSOIP telemedicine stethoscope software that enables the stethoscope stream to go ... PCP-SSP and works with RNK’s flagship PCP-USB stethoscope. , Remote auscultation involves two ...
(Date:5/2/2016)... ... ... As directed by its board of directors during its April 26 meeting, The ... nurse practitioners (CNP) to practice to the full scope of their license without the ... and 3,600 hours. , In addition, HAP supports CNPs who are licensed in another ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... ... educational website to help consumers better understand life insurance throughout various life stages. ... including an easy-to-use life insurance needs calculator and content specific to the times ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... ORANGE COUNTY, Calif. , April 29, 2016 ... technology industry is projected to shift from systems ... can replace all types of modality CRT Medical ... set-up." Although there are a host of foreseeable ... a serious concern; will existing modalities have to ...
(Date:4/29/2016)... 2016 Interview ... Sanofi, leader mondial et diversifié ... pour le premier trimestre 2016. Le ... commente les résultats du premier trimestre ... le reste de l,année. ...
(Date:4/28/2016)... 2016   Click here for supplemental information ... DPLO), the nation,s largest independent specialty pharmacy, announced ... to acquire Valley Campus Pharmacy, Inc., doing business ... specialty pharmacy that provides individualized patient care, based ... In 2015, TNH generated approximately $400 million in ...
Breaking Medicine Technology: